Journey Medical Corp - Common Stock (DERM)

Historical Holders from Q4 2021 to Q3 2025

Symbol
DERM on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
17,194,910
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
8,559,886
Holdings value
$60,983,766
% of all portfolios
0%
Number of holders
66
Number of buys
36
Number of sells
-21
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Journey Medical Corp - Common Stock (DERM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TANG CAPITAL MANAGEMENT LLC 8% $14,020,746 1,854,596 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
WASATCH ADVISORS LP 6.7% +26% $7,972,248 +$1,532,476 1,152,059 +23.8% WASATCH ADVISORS LP 30 Jun 2025

Institutional Holders of Journey Medical Corp - Common Stock (DERM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 8,559,886 $60,983,766 +$15,779,279 $7.12 66
2025 Q2 6,494,302 $46,629,314 +$11,145,137 $7.18 56
2025 Q1 5,017,760 $29,603,817 +$7,390,927 $5.9 38
2024 Q4 3,813,405 $14,909,751 +$6,149,987 $3.91 38
2024 Q3 2,156,982 $12,186,357 -$1,194,242 $5.65 36
2024 Q2 2,360,259 $13,310,203 +$3,384,583 $5.64 35
2024 Q1 1,816,385 $6,678,973 +$973,921 $3.68 31
2023 Q4 1,341,390 $7,982,763 -$492,957 $5.76 34
2023 Q3 2,135,266 $5,850,655 +$1,401,524 $2.74 20
2023 Q2 1,652,825 $2,627,537 -$24,753 $1.59 19
2023 Q1 1,668,350 $2,620,320 -$179,207 $1.57 16
2022 Q4 2,672,478 $5,131,893 -$313,986 $1.92 18
2022 Q3 1,878,524 $4,621,000 +$328,580 $2.46 18
2022 Q2 1,759,431 $6,580,100 +$289,703 $3.74 12
2022 Q1 1,644,289 $7,940,000 +$35,914 $4.83 13
2021 Q4 1,627,492 $8,756,000 +$8,756,000 $5.38 14